Amarin recently announced its earnings for Q2’22 with mixed results. Here we’ll examine the pros and cons of having this penny stock in your portfolio.
© 2023 The Abundance Pub. All rights reserved.
All trademarks and service marks are the property of their respective owners. This site is not intended to provide, and does not constitute, medical, health, legal, investment, financial or other professional advice.